Development of monoclonal antibodies for quantification of bovine tumor necrosis factor-α

被引:0
|
作者
Sipka, Anja [1 ]
Babasyan, Susanna [1 ]
Mann, Sabine [1 ]
Freer, Heather [1 ]
Klaessig, Suzanne [1 ]
Wagner, Bettina [1 ]
机构
[1] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA
来源
JDS COMMUNICATIONS | 2021年 / 2卷 / 06期
基金
美国食品与农业研究所;
关键词
TNF-ALPHA; CYTOKINE PRODUCTION; ESCHERICHIA-COLI; CELLS; PHOSPHORYLATION; EXPRESSION; MONOCYTES; RESPONSES; ELISA; LPS;
D O I
暂无
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The expression of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) is associated with production losses in dairy cows and is a hallmark of early inflammatory processes. Reliable tools for the detection and quantification of soluble as well as cytoplasmatic bovine TNF-alpha are needed to deepen our understanding of inflammatory dynamics in dairy cows. The objective of this study was to generate a monoclonal antibody (mAb) pair that could be used to quantify bovine TNF-alpha in cell culture supernatants and plasma and to detect cytoplasmatic TNF-alpha in bovine leukocyte populations. One mouse was immunized with a recombinant fusion protein of bovine TNF-alpha and equine IL-4 generated in Chinese hamster ovary cells. Murine monoclonal antibodies specific to bovine TNF-alpha were produced in hybridoma cell lines and selected based on their specificity to the recombinant IL-4/TNF-alpha protein. Clones 197-1 and 65-2, both murine IgG1 isotypes, detected the bovine TNF-alpha fusion protein as well as the native protein produced by peripheral blood mononuclear cells (PBMC) stimulated with a combination of phorbol myristate acetate and ionomycin. Both mAbs were tested for and lacked cross-reactivity to equine IL-4 and 3 other recombinant bovine cytokines (IFN-gamma, IL-10, and CCL5) and were used to develop a fluorescent bead-based assay. The range of bovine TNF-alpha detection in the assay was 0.2 to 620 ng/mL, and the test was used to quantify native bovine TNF-alpha in cell culture supernatants of stimulated PBMC and in plasma from ex vivo whole-blood stimulations. Sample matrices were spiked with TNF-alpha, with subsequent recovery rates (mean +/- SD) of 89% +/- 9 (n = 3) in culture medium and 94% +/- 12 (n = 3) in heat-inactivated fetal bovine serum. Serial dilutions of plasma and cell culture supernatants from stimulated whole blood or PBMC indicated excellent accuracy for quantification of native TNF-alpha in bovine samples. Both bovine TNF-alpha mAbs also detected intracellular TNF-alpha in bovine CD14(+) monocytes and CD4(+)/CD8(+) lymphocytes. In conclusion, we demonstrated that the mAbs generated provide valuable new tools to quantify native bovine TNF-alpha in a wide concentration range and to characterize intracellular TNF-alpha expression in bovine leukocytes.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Tumor necrosis factor-α and neuronal development
    Bessis, A
    Bernard, D
    Triller, A
    NEUROSCIENTIST, 2005, 11 (04): : 277 - 281
  • [2] Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology
    Lee, Thomas W.
    Fedorak, Richard N.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) : 543 - +
  • [3] Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
    Ceyhan Ceran
    Murat Cokol
    Sultan Cingoz
    Ipek Tasan
    Mehmet Ozturk
    Tamer Yagci
    BMC Cancer, 12
  • [4] Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
    Ceran, Ceyhan
    Cokol, Murat
    Cingoz, Sultan
    Tasan, Ipek
    Ozturk, Mehmet
    Yagci, Tamer
    BMC CANCER, 2012, 12
  • [5] Development of a sensitive ELISA for the quantification of human tumour necrosis factor-α using 4 polyclonal antibodies
    Grebenchtchikov, N
    van der Ven-Jongekrijg, J
    Pesman, GJ
    Geurts-Moespot, A
    van der Meer, JWM
    Sweep, FCGJ
    EUROPEAN CYTOKINE NETWORK, 2005, 16 (03) : 215 - 222
  • [6] Comparison of specific adsorbents for tumor necrosis factor-α and therapeutic anti-tumor necrosis factor-α antibodies:: An in vitro sepsis model
    Schwanzer-Pfeiffer, D.
    Mitteregger, R.
    Rossmanith, E.
    Falkenhagen, D.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2006, 29 (12): : 1140 - 1147
  • [7] Comparison of specific adsorbents for tumor necrosis factor-α and therapeutic anti-tumor necrosis factor-α antibodies: An in vitro sepsis model
    Schwanzer-Pfeiffer, Dagmar
    Mitteregger, R.
    Rossmanith, E.
    Falkenhagen, D.
    International Journal of Artificial Organs, 2006, 29 (12): : 1140 - 1147
  • [8] Antibodies to tumor necrosis factor-α in the treatment of Crohn's disease
    Brown, SJ
    Abreu, MT
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (02) : 160 - 168
  • [9] New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease
    Slevin, Stephanie M.
    Egan, Laurence J.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (12) : 2909 - 2920
  • [10] Tumor necrosis factor-α and the development of multiple organ failure
    Moldawer, LL
    Minter, RM
    CRITICAL CARE MEDICINE, 2000, 28 (06) : 2158 - 2159